Editorial comment: Nevirapine hepatotoxicity - An important clinical issue

AIDS Reader

Volumn 11, Issue 11, 2001, Pages 579-

  Harris, M ^a   Montaner, J S G ^a  

^a ST PAUL S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

NEVIRAPINE;

ANOREXIA; CLINICAL FEATURE; DRUG CONTRAINDICATION; DRUG EFFECT; DRUG HYPERSENSITIVITY; DRUG INDICATION; DRUG INDUCED DISEASE; EOSINOPHILIA; FATIGUE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; JAUNDICE; LIVER TOXICITY; MALAISE; NAUSEA; NOTE; RASH; RISK FACTOR; SYMPTOM;

EID: 0035207010     PISSN: 10530894     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (9)

1. Nevirapine-induced hepatitis treated with corticosteroids?
2. DRESS (drug rash with eosinophilia and systemic symptoms) syndrome associated with nevirapine therapy
3. Adverse effects associated with use of nevirapine in HIV postexposure prophylaxis for 2 health care workers
4. Nevirapine: A review of its development pharmacological profile and potential for clinical use
5. Adverse effects associated with use of nevirapine in HIV postexposure prophylaxis for 2 health care workers
6. Severe hepatic failure related to nevirapine treatment
7. + levels, hepatitis B and C seropositivity, and baseline liver function tests
8. Serious nevirapine hepatotoxicity with HIV postexposure prophylaxis